发明名称 CALCINEURIN REGULATABLE ADENYLATE CYCLASE
摘要 There is provided a novel adenylate cyclase enzyme, the nucleotide sequence of which is set out in SEQ ID No. 1. The activity of the adenylate cyclase is uniquely regulated by calcineurin, a protein phosphatase. The calcineurin binding site has been identified at amino acids 503 to 610 of the novel adenylate cyclase. Regulation of the novel adenylate cyclase may be useful in treating certain disorders. Suitable regulators include agents which bind to the 503-610 amino acid site and include calcineurin, its activators, inhibitors and competitors and antibodies specific to that site. Specific disorders include neurological disorders such as Parkinsons' disease, cardiovascular disorders such as angina pectoris and tumors, especially ovarian tumors.
申请公布号 WO9625502(A1) 申请公布日期 1996.08.22
申请号 WO1996GB00312 申请日期 1996.02.14
申请人 MEDICAL RESEARCH COUNCIL;ANTONI, FERENC;PATERSON, JANICE, MACKENZIE 发明人 ANTONI, FERENC;PATERSON, JANICE, MACKENZIE
分类号 C12N15/09;A61K38/00;A61K38/13;A61K38/16;A61K38/46;A61K45/00;A61K45/06;A61K48/00;A61K49/00;A61P1/00;A61P9/00;A61P11/00;A61P13/02;A61P15/00;A61P25/00;A61P35/00;A61P43/00;C07K14/47;C07K16/40;C12N5/10;C12N9/88;C12N15/60;C12R1/91;(IPC1-7):C12N15/60;C12N15/79;A61K39/395;G01N33/573;A61K31/135 主分类号 C12N15/09
代理机构 代理人
主权项
地址